Integrating Analytical Method Development and Quality Control
A Roadmap for Successful Advanced Therapy Development
Landmark Bio’s Mission to Prevent Cell Therapy ‘Do-overs’
Drug Discovery and Development interviews Landmark Bio CEO Ran Zheng on the realities of large-scale cell and gene therapy manufacturing and the need to incorporate the requirements for GMP and commercial manufacturing early on
Integrating AI & ML in Biotech Manufacturing: How Modern Technology is Revolutionizing the Production of Advanced Therapies
An MIT Sloan Career Development Office Conversation with Ran Zheng, CEO of Landmark Bio
Getting Tech Transfer Right First Time
A digital thread centric integrated IT/OT foundation
Optimization of In Vitro Transcription for mRNA Production
Millicent Lin, R.K. DeLong, Mathew Brier, Manish Tandon, Li-wen Wang, Yun Chen, Radouane Zouaoui, Aviva Joseph, Eli Kraus and Gregg Nyberg
Use of Conventional Flow Cytometry to Study Extracellular Vesicles
Eli Kraus, Yun Chen, Manish Tandon, Gregg Nyberg
Formulation Matters
RNA Nanoparticle Formulation, Process and Characterization R.K. DeLong, M.S., PhD and Eli Kraus PhD